SEQUENT SCIENTIFIC
|
The Current P/E Ratio of SEQUENT SCIENTIFIC is 133.56.
| Share Price | ₹216.3 | Nov 06,2025 |
| Market Cap | ₹5,445.2 Cr | |
| Earnings-TTM | ₹40.8 Cr | TTM-Consolidated Results |
| Price/Earnings | 133.56x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SEQUENT SCIENTIFIC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹5,445.2 Cr] as on Nov 06,2025
(/) Earnings [ ₹40.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 133.56x ]
Thus, for SEQUENT SCIENTIFIC , the investors are currently willing to pay 133.56 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SEQUENT SCIENTIFIC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SEQUENT SCIENTIFIC over the last five years.
Historical PE (Price/Earnings) ratio chart of SEQUENT SCIENTIFIC
PE Ratio Performance Analysis for SEQUENT SCIENTIFIC
- SEQUENT SCIENTIFIC 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 58.69x.
- SEQUENT SCIENTIFIC 's operated at median p/e ratio of 62.69x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SEQUENT SCIENTIFIC 's p/e ratio peaked in Mar2025 at 149.64x.
- SEQUENT SCIENTIFIC 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does SEQUENT SCIENTIFIC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SEQUENT SCIENTIFIC | 40.77 | 133.56 | 5,445.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 38.46 | 404,468.0 |
| DIVIS LABORATORIES LTD | 2,306.00 | 79.28 | 182,810.0 |
| CIPLA LTD | 5,453.86 | 22.22 | 121,170.0 |
| TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.09 | 120,300.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.58 | 100,575.0 |
| MANKIND PHARMA LTD | 1,767.06 | 53.94 | 95,320.4 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.94 | 94,208.7 |
| LUPIN LTD | 3,722.18 | 24.00 | 89,345.0 |
| AUROBINDO PHARMA LTD | 3,447.75 | 19.21 | 66,243.3 |
| ABBOTT INDIA LTD | 1,508.95 | 41.51 | 62,639.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SEQUENT SCIENTIFIC 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.58x |
| Max industry PE | 133.56x |
| Median industry PE | 38.46x |
| Average industry PE | 46.25x |
You may also like the below Video Courses